Global Drug Repurposing Market Insights, Forecast to 2025

Global Drug Repurposing Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Drug Repurposing Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Drug Repurposing Market Size Growth Rate by Product
1.4.2 Oncology
1.4.3 CNS Diseases
1.4.4 Neurodegenerative Diseases
1.4.5 Others
1.5 Market by End User
1.5.1 Global Drug Repurposing Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Drug Repurposing Market Size
2.1.1 Global Drug Repurposing Revenue 2014-2025
2.1.2 Global Drug Repurposing Sales 2014-2025
2.2 Drug Repurposing Growth Rate by Regions
2.2.1 Global Drug Repurposing Sales by Regions
2.2.2 Global Drug Repurposing Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Drug Repurposing Sales by Manufacturers
3.1.1 Drug Repurposing Sales by Manufacturers
3.1.2 Drug Repurposing Sales Market Share by Manufacturers
3.1.3 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.2 Drug Repurposing Revenue by Manufacturers
3.2.1 Drug Repurposing Revenue by Manufacturers (2014-2019)
3.2.2 Drug Repurposing Revenue Share by Manufacturers (2014-2019)
3.3 Drug Repurposing Price by Manufacturers
3.4 Drug Repurposing Manufacturing Base Distribution, Product Types
3.4.1 Drug Repurposing Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drug Repurposing Product Type
3.4.3 Date of International Manufacturers Enter into Drug Repurposing Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Drug Repurposing Sales by Product
4.2 Global Drug Repurposing Revenue by Product
4.3 Drug Repurposing Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Drug Repurposing Breakdown Data by End User
6 North America
6.1 North America Drug Repurposing by Countries
6.1.1 North America Drug Repurposing Sales by Countries
6.1.2 North America Drug Repurposing Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Drug Repurposing by Product
6.3 North America Drug Repurposing by End User
7 Europe
7.1 Europe Drug Repurposing by Countries
7.1.1 Europe Drug Repurposing Sales by Countries
7.1.2 Europe Drug Repurposing Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drug Repurposing by Product
7.3 Europe Drug Repurposing by End User
8 Asia Pacific
8.1 Asia Pacific Drug Repurposing by Countries
8.1.1 Asia Pacific Drug Repurposing Sales by Countries
8.1.2 Asia Pacific Drug Repurposing Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Drug Repurposing by Product
8.3 Asia Pacific Drug Repurposing by End User
9 Central & South America
9.1 Central & South America Drug Repurposing by Countries
9.1.1 Central & South America Drug Repurposing Sales by Countries
9.1.2 Central & South America Drug Repurposing Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Drug Repurposing by Product
9.3 Central & South America Drug Repurposing by End User
10 Middle East and Africa
10.1 Middle East and Africa Drug Repurposing by Countries
10.1.1 Middle East and Africa Drug Repurposing Sales by Countries
10.1.2 Middle East and Africa Drug Repurposing Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Drug Repurposing by Product
10.3 Middle East and Africa Drug Repurposing by End User
11 Company Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Company Business Overview
11.1.3 Astellas Pharma Drug Repurposing Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Astellas Pharma Drug Repurposing Products Offered
11.1.5 Astellas Pharma Recent Development
11.2 Biovista
11.2.1 Biovista Company Details
11.2.2 Company Business Overview
11.2.3 Biovista Drug Repurposing Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Biovista Drug Repurposing Products Offered
11.2.5 Biovista Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Drug Repurposing Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Drug Repurposing Products Offered
11.3.5 Novartis Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 Company Business Overview
11.4.3 AbbVie Drug Repurposing Sales, Revenue and Gross Margin (2014-2019)
11.4.4 AbbVie Drug Repurposing Products Offered
11.4.5 AbbVie Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Drug Repurposing Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Pfizer Drug Repurposing Products Offered
11.5.5 Pfizer Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Company Business Overview
11.6.3 Allergan Drug Repurposing Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Allergan Drug Repurposing Products Offered
11.6.5 Allergan Recent Development
11.7 NuMedii
11.7.1 NuMedii Company Details
11.7.2 Company Business Overview
11.7.3 NuMedii Drug Repurposing Sales, Revenue and Gross Margin (2014-2019)
11.7.4 NuMedii Drug Repurposing Products Offered
11.7.5 NuMedii Recent Development
12 Future Forecast
12.1 Drug Repurposing Market Forecast by Regions
12.1.1 Global Drug Repurposing Sales Forecast by Regions 2019-2025
12.1.2 Global Drug Repurposing Revenue Forecast by Regions 2019-2025
12.2 Drug Repurposing Market Forecast by Product
12.2.1 Global Drug Repurposing Sales Forecast by Product 2019-2025
12.2.2 Global Drug Repurposing Revenue Forecast by Product 2019-2025
12.3 Drug Repurposing Market Forecast by End User
12.4 North America Drug Repurposing Forecast
12.5 Europe Drug Repurposing Forecast
12.6 Asia Pacific Drug Repurposing Forecast
12.7 Central & South America Drug Repurposing Forecast
12.8 Middle East and Africa Drug Repurposing Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drug Repurposing Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Drug Repurposing Product Picture
Table Drug Repurposing Market Segments
Table Key Manufacturers Drug Repurposing Covered
Table Global Drug Repurposing Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Drug Repurposing Sales Market Share by Product 2014-2025
Figure Oncology Product Picture
Table Major Manufacturers of Oncology
Figure CNS Diseases Product Picture
Table Major Manufacturers of CNS Diseases
Figure Neurodegenerative Diseases Product Picture
Table Major Manufacturers of Neurodegenerative Diseases
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Drug Repurposing Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Hospitals
Figure Ambulatory Surgical Centers
Figure Others
Figure Drug Repurposing Report Years Considered
Figure Global Drug Repurposing Market Size 2014-2025 (Million US$)
Figure Global Drug Repurposing Sales 2014-2025 (K MT)
Table Global Drug Repurposing Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Drug Repurposing Sales by Regions 2014-2019 (K MT)
Table Global Drug Repurposing Sales Market Share by Regions 2014-2019
Figure Global Drug Repurposing Sales Market Share by Regions 2014-2019
Figure 2018 Global Drug Repurposing Sales Market Share by Regions
Table Global Drug Repurposing Revenue by Regions 2014-2019 (Million US$)
Table Global Drug Repurposing Revenue Market Share by Regions 2014-2019
Figure Global Drug Repurposing Revenue Market Share by Regions 2014-2019
Figure 2018 Global Drug Repurposing Revenue Market Share by Regions
Table Global Drug Repurposing Sales by Manufacturers (2014-2019) (K MT)
Table Global Drug Repurposing Sales Share by Manufacturers (2014-2019)
Figure Global Drug Repurposing Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Drug Repurposing Revenue by Manufacturers (2014-2019) (Million USD)
Table Drug Repurposing Revenue Share by Manufacturers (2014-2019)
Figure Drug Repurposing Value Share by Manufacturers in 2018
Table Key Manufacturers Drug Repurposing Price (2014-2019) (USD/MT)
Table Drug Repurposing Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Drug Repurposing Product Type
Table Date of International Manufacturers Enter into Drug Repurposing Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Drug Repurposing Sales by Product (2014-2019) (K MT)
Table Global Drug Repurposing Sales Share by Product (2014-2019)
Figure Global Drug Repurposing Sales Market Share by Product (2014-2019)
Figure Global Drug Repurposing Sales Market Share by Product in 2018
Table Global Drug Repurposing Revenue by Product (2014-2019) (Million US$)
Table Global Drug Repurposing Revenue Share by Product (2014-2019)
Figure Global Drug Repurposing Revenue Market Share by Product (2014-2019)
Figure Global Drug Repurposing Revenue Market Share by Product in 2018
Table Drug Repurposing Price by Product 2014-2019 (USD/MT)
Table Global Drug Repurposing Sales by End User (2014-2019) (K MT)
Table Global Drug Repurposing Sales Share by End User (2014-2019)
Figure Global Sales Drug Repurposing Market Share by End User (2014-2019)
Figure Global Sales Drug Repurposing Market Share by End User in 2018
Figure North America Drug Repurposing Sales Growth Rate 2014-2019 (K MT)
Figure North America Drug Repurposing Revenue Growth Rate 2014-2019 (Million US$)
Table North America Drug Repurposing Sales by Countries (2014-2019) (K MT)
Table North America Drug Repurposing Sales Market Share by Countries (2014-2019)
Figure 2018 North America Drug Repurposing Sales Market Share by Countries
Table North America Drug Repurposing Revenue by Countries (2014-2019) (Million US$)
Table North America Drug Repurposing Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Drug Repurposing Revenue Market Share by Countries
Figure United States Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure United States Drug Repurposing Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Canada Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Table North America Drug Repurposing Sales by Product (2014-2019) (K MT)
Table North America Drug Repurposing Sales Market Share by Product (2014-2019)
Figure 2018 North America Drug Repurposing Market Share by Product
Table North America Drug Repurposing Sales by End User (2014-2019) (K MT)
Table North America Drug Repurposing Sales Market Share by End User (2014-2019)
Figure 2018 North America Drug Repurposing Market Share by End User
Figure Europe Drug Repurposing Sales Growth Rate 2014-2019 (K MT)
Figure Europe Drug Repurposing Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Drug Repurposing Sales by Countries (2014-2019) (K MT)
Table Europe Drug Repurposing Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Drug Repurposing Sales Market Share by Countries
Table Europe Drug Repurposing Revenue by Countries (2014-2019) (Million US$)
Table Europe Drug Repurposing Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Drug Repurposing Revenue Market Share by Countries
Figure Germany Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Germany Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure France Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure France Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure UK Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Italy Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Russia Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Drug Repurposing Sales by Product (2014-2019) (K MT)
Table Europe Drug Repurposing Sales Market Share by Product (2014-2019)
Figure 2018 Europe Drug Repurposing Market Share by Product
Table Europe Drug Repurposing Sales by End User (2014-2019) (K MT)
Table Europe Drug Repurposing Sales Market Share by End User (2014-2019)
Figure 2018 Europe Drug Repurposing Market Share by End User
Figure Asia Pacific Drug Repurposing Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Drug Repurposing Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Drug Repurposing Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Drug Repurposing Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Drug Repurposing Sales Market Share by Countries
Table Asia Pacific Drug Repurposing Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Drug Repurposing Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Drug Repurposing Revenue Market Share by Countries
Figure China Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure China Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Japan Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Korea Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure India Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure India Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Australia Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Drug Repurposing Sales by Product (2014-2019) (K MT)
Table Asia Pacific Drug Repurposing Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Drug Repurposing Market Share by Product
Table Asia Pacific Drug Repurposing Sales by End User (2014-2019) (K MT)
Table Asia Pacific Drug Repurposing Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Drug Repurposing Market Share by End User
Figure Central & South America Drug Repurposing Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Drug Repurposing Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Drug Repurposing Sales by Countries (2014-2019) (K MT)
Table Central & South America Drug Repurposing Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Drug Repurposing Sales Market Share by Countries
Table Central & South America Drug Repurposing Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Drug Repurposing Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Drug Repurposing Revenue Market Share by Countries
Figure Brazil Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Drug Repurposing Sales by Product (2014-2019) (K MT)
Table Central & South America Drug Repurposing Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Drug Repurposing Market Share by Product
Table Central & South America Drug Repurposing Sales by End User (2014-2019) (K MT)
Table Central & South America Drug Repurposing Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Drug Repurposing Market Share by End User
Figure Middle East and Africa Drug Repurposing Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Drug Repurposing Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Drug Repurposing Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Drug Repurposing Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Drug Repurposing Sales Market Share by Countries
Table Middle East and Africa Drug Repurposing Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Drug Repurposing Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Drug Repurposing Revenue Market Share by Countries
Figure GCC Countries Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Drug Repurposing Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Drug Repurposing Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Drug Repurposing Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Drug Repurposing Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Drug Repurposing Market Share by Product
Table Middle East and Africa Drug Repurposing Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Drug Repurposing Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Drug Repurposing Market Share by End User
Table Astellas Pharma Company Details
Table Astellas Pharma Drug Repurposing Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Astellas Pharma Recent Development
Table Biovista Company Details
Table Biovista Drug Repurposing Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Biovista Recent Development
Table Novartis Company Details
Table Novartis Drug Repurposing Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table AbbVie Company Details
Table AbbVie Drug Repurposing Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Pfizer Company Details
Table Pfizer Drug Repurposing Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Allergan Company Details
Table Allergan Drug Repurposing Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table NuMedii Company Details
Table NuMedii Drug Repurposing Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table NuMedii Recent Development
Table Global Drug Repurposing Sales Forecast by Regions 2019-2025 (K MT)
Table Global Drug Repurposing Sales Market Share Forecast by Regions 2019-2025
Table Global Drug Repurposing Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Drug Repurposing Revenue Market Share Forecast by Regions 2019-2025
Table Global Drug Repurposing Sales Forecast by Product 2019-2025 (K MT)
Table Global Drug Repurposing Sales Market Share Forecast by Product 2019-2025
Table Global Drug Repurposing Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Drug Repurposing Revenue Market Share Forecast by Product 2019-2025
Table Global Drug Repurposing Sales Forecast by End User 2019-2025 (K MT)
Table Global Drug Repurposing Sales Market Share Forecast by End User 2019-2025
Figure North America Drug Repurposing Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Drug Repurposing Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Drug Repurposing Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Drug Repurposing Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Drug Repurposing Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Drug Repurposing Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Drug Repurposing Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Drug Repurposing Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Drug Repurposing Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Drug Repurposing Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Drug Repurposing Value Chain
Table Drug Repurposing Customers List
Table Drug Repurposing Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs